In experimental autoimmune encephalitis (EAE), an animal model of MS, administering agonists to activate AhR suppresses disease progression [20, 23, 24], whereas inhibiting AhR and its immunosuppressive function promotes immune responses and exacerbates EAE [25]. This evidence concerns the gene AHR and myeloid sarcoma.